Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2023-08-09 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(제3자배정 유상증자(채무상계))
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocated capital increase via debt-equity swap). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-08-09 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company (Apures Co., Ltd.) detailing a decision for a third-party capital increase (유상증자결정). This document outlines the issuance of new shares, the purpose of the capital raise (debt-to-equity swap/financial restructuring), and the specific details of the third-party allocation. In the context of financial filings, announcements regarding new share issues, capital changes, or equity financing are classified under 'Share Issue/Capital Change'.
2023-07-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements (pledges) of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-07-20 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) from a Korean company, Apures Co., Ltd. It contains detailed financial statements, management discussion and analysis, governance information, and auditor opinions. It is a comprehensive annual filing submitted to the Financial Supervisory Service (FSS) in Korea. According to the provided definitions, this corresponds to an Annual Report (10-K). FY 2022
2023-07-17 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) meeting held by the company '아퓨어스'. It provides the date, location, attendees, and agenda of the meeting, and confirms that the IR materials have been posted to the Korea Exchange (KRX) system. Since it is a brief notification regarding the occurrence of an event and the availability of materials rather than the presentation deck itself, it falls under the category of a regulatory announcement regarding report/event publication.
2023-05-26 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling and details of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves or a financial report, and it does not fit into other specific categories like M&A or dividends, it is classified as a Regulatory Filing (RNS) as it serves as a formal notice to the market.
2023-04-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.